| Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets AE Kudinov, J Karanicolas, EA Golemis, Y Boumber Clinical Cancer Research 23 (9), 2143-2153, 2017 | 271 | 2017 |
| Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis AE Kudinov, A Deneka, AS Nikonova, TN Beck, YH Ahn, X Liu, ... Proceedings of the National Academy of Sciences 113 (25), 6955-6960, 2016 | 145 | 2016 |
| Anti-Müllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer TN Beck, VA Korobeynikov, AE Kudinov, R Georgopoulos, NR Solanki, ... Cell reports 16 (3), 657-671, 2016 | 71 | 2016 |
| CAS proteins in health and disease: an update AS Nikonova, AV Gaponova, AE Kudinov, EA Golemis IUBMB life 66 (6), 387-395, 2014 | 64 | 2014 |
| A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer AV Gaponova, AS Nikonova, AY Deneka, MC Kopp, AE Kudinov, ... Clinical Cancer Research 22 (20), 5120-5129, 2016 | 32 | 2016 |
| Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC) P Makhov, I Bychkov, B Faezov, A Deneka, A Kudinov, E Nicolas, ... Oncogenesis 10 (3), 29, 2021 | 22 | 2021 |
| Case report: reinitiating pembrolizumab treatment after small bowel perforation TN Beck, AE Kudinov, E Dulaimi, Y Boumber BMC cancer 19, 1-9, 2019 | 20 | 2019 |
| Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer I Bychkov, I Topchu, P Makhov, A Kudinov, JD Patel, Y Boumber Cancers 15 (9), 2529, 2023 | 3 | 2023 |
| Transforming Growth Factor Beta (TGF-β) Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC) AE Kudinov, TN Beck Molecular Determinants of Head and Neck Cancer, 89-115, 2018 | 3 | 2018 |
| Musashi-2 (MSI2) regulation of ERBB family proteins in non-small cell lung cancer (NSCLC) A Kudinov, A Deneka, AN Nikonova, E Nicolas, VA Korobeynikov, ... Cancer Research 77 (13_Supplement), 3878-3878, 2017 | 1 | 2017 |
| Musashi-2 (MSI2) drives TGFBR1/SMAD3 dependent partial EMT and supports VEGFR2 expression and metastasis of human and mouse NSCLC cells A Kudinov, A Deneka, A Nikonova, I Serebriiskii, TN Beck, Q Cai, ... Cancer Research 76 (14_Supplement), 1584-1584, 2016 | 1 | 2016 |
| Musashi-2 (MSI2) activates TGF-β signaling and inhibits CLDN7 to promote non-small cell lung cancer (NSCLC) metastasis A Kudinov, AD Deneka, A Nikonova, YH Ahn, XL Liu, I Serebriiskii, ... Cancer Research 75 (15_Supplement), 4098-4098, 2015 | 1 | 2015 |
| MSI2 regulates VEGFR2 signaling and tumor progression in NSCLC I Bychkov, A Deneka, I Topchu, P Makhov, A Kudinov, A Nikonova, ... Cancer Research 82 (12_Supplement), 874-874, 2022 | | 2022 |
| Musashi-2 regulates EGFR expression in NSCLC, cell proliferation and survival, response to EGFR inhibitors in EGFR-mutant NSCLC A Kudinov, P Makhov, B Faezov, I Bychkov, A Deneka, E Nicolas, ... Cancer Research 79 (13_Supplement), 955-955, 2019 | | 2019 |
| Musashi-2 regulates EGFR/HER3 expression in NSCLC, cell proliferation and response to EGFR inhibitors in EGFR-mutant NSCLC P Makhov, A Kudinov, A Deneka, BL Egleston, E Nicolas, KQ Cai, ... Cancer Research 78 (13_Supplement), 4452-4452, 2018 | | 2018 |
| Abstract B25: Anti-Mullerian hormone (AMH) supports epithelial identity and survival signaling in lung cancer TN Beck, V Korobeynikov, A Kudinov, R Georgeopoulos, E Nicolas, ... Cancer Research 76 (3_Supplement), B25-B25, 2016 | | 2016 |
| The Novel HSP90 Inhibitor-SN-38 Conjugate (STA-12-8666), Is Highly Active in Preclinical Models of Small Cell Lung Cancer (SCLC) Y Boumber, A Gaponova, A Nikonova, A Deneka, A Kudinov, M Kopp, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S399-S399, 2015 | | 2015 |
| Preclinical efficacy of STA-12-8666, an HSP90 inhibitor-targeted SN-38 conjugate, in small cell lung cancer (SCLC). Y Boumber, A Gaponova, AS Nikonova, A Deneka, A Kudinov, ... Journal of Clinical Oncology 33 (15_suppl), e18560-e18560, 2015 | | 2015 |
| Anti-Mullerian hormone regulates epithelial plasticity and survival signaling in non-small cell lung cancer. TN Beck, VA Korobeynikov, AE Kudinov, R Georgopoulos, E Nicolas, ... MOLECULAR BIOLOGY OF THE CELL 26, 2015 | | 2015 |
| Musashi-2 (Msi-2) drives metastasis of non-small cell lung cancer (NSCLC) AE Kudinov, A Nikonova, A Deneka, X Liu, IG Serebriiskii, MD Andrake, ... MOLECULAR BIOLOGY OF THE CELL 25, 2014 | | 2014 |
